These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1895417)

  • 21. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
    Ferrière JM; Gaston R; Piechaud T; Le Guillou M
    Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
    Floth A; Schramek P
    J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial.
    Keogh EJ; Watters GR; Earle CM; Carati CJ; Wisniewski ZS; Tulloch GS; Lord DJ
    J Urol; 1989 Sep; 142(3):726-8. PubMed ID: 2671414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence.
    Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC
    J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic.
    Armstrong DK; Convery A; Dinsmore WW
    Int J STD AIDS; 1993; 4(4):214-6. PubMed ID: 8399501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracavernous injections: still the gold standard for treatment of erectile dysfunction in elderly men.
    Richter S; Vardi Y; Ringel A; Shalev M; Nissenkorn I
    Int J Impot Res; 2001 Jun; 13(3):172-5. PubMed ID: 11525316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.
    Montorsi F; Guazzoni G; Bergamaschi F; Zucconi M; Rigatti P; Pizzini G; Miani A; Pozza G
    Acta Diabetol; 1994 Apr; 31(1):1-5. PubMed ID: 8043890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the immediate and long-term effects of pharmacologically induced penile erections in the treatment of psychogenic and organic impotence.
    Kiely EA; Williams G; Goldie L
    Br J Urol; 1987 Feb; 59(2):164-9. PubMed ID: 3828713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
    Stief CG; Wetterauer U; Kulvelis F; Popken G; Staubesand J; Sommerkamp H
    Urol Int; 1990; 45(6):321-5. PubMed ID: 2288047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracavernous injections for impotence.
    Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
    [No Abstract]   [Full Text] [Related]  

  • 32. Vasoactive intracavernous pharmacotherapy.
    Sidi AA
    Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of sexual dysfunction for management of intracavernous medication-induced erections.
    Fein RL
    J Urol; 1990 Feb; 143(2):298-301. PubMed ID: 1688954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male.
    Bell DS; Cutter GR; Hayne VB; Lloyd LK
    Urology; 1992 Jul; 40(1):36-40. PubMed ID: 1621310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury.
    Bodner DR; Lindan R; Leffler E; Kursh ED; Resnick MI
    J Urol; 1987 Aug; 138(2):310-1. PubMed ID: 3599245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical treatment of impotence with papaverine and phentolamine intracavernosal injection.
    Dinsmore WW
    Ulster Med J; 1990 Oct; 59(2):174-6. PubMed ID: 2278115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Priapism: an avoidable complication of pharmacologically induced erection.
    Fouda A; Hassouna M; Beddoe E; Kalogeropoulos D; Binik YM; Elhilali MM
    J Urol; 1989 Oct; 142(4):995-7. PubMed ID: 2795759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.